Hypertriglyceridemia
📧 Sign up to get email alerts when something new happens for Hypertriglyceridemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-06-05FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2014-05-14FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2014-04-07FDA Approved: OMEGA-3-ACID ETHYL ESTERS — Original Application (KD Pharma USA, Inc.)
FDA approved the original application for Omega-3-Acid Ethyl Esters from KD Pharma USA, a generic version of the prescription therapy indica…
-
FDA approval · 2014-03-20FDA Approved: NIACIN — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original abbreviated new drug application for NIACIN, a generic nicotinic acid product.
-
FDA approval · 2014-02-26FDA Approved: VASCEPA — Supplemental Application (Amarin Pharma Inc.)
FDA approves a supplemental application for Vascepa (icosapent ethyl), expanding its labeling to address cardiovascular risk reduction in ad…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-12-04FDA Approved: FENOFIBRIC ACID — Original Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' original application for fenofibric acid, a lipid-lowering agent indicated for certain lipid disorde…
-
FDA approval · 2013-11-15FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
FDA approves a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2013-10-18FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Fenofibrate submitted by Lupin Pharmaceuticals, Inc. This indicates a change or addition to …
-
FDA approval · 2013-09-11FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC. This approval likel…
-
FDA approval · 2013-08-06FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for fenofibrate from Rhodes Pharmaceuticals L.P., authorizing a new generic version of the drug.
-
FDA approval · 2013-07-26FDA Approved: FENOFIBRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approves a supplemental application for fenofibrate from Mylan Pharmaceuticals Inc., approving changes to the approved generic product.
-
FDA approval · 2013-07-26FDA Approved: FENOFIBRATE — Original Application (Apotex Corp.)
The FDA approves the original (ANDA) application for fenofibrate from Apotex Corp., granting generic approval for the lipid-lowering medicin…
-
FDA approval · 2013-06-26FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2013-01-28FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for fenofibric acid submitted by Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2012-12-19FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for Fenofibrate, updating the product labeling and/or approvals under a sup…
-
FDA approval · 2012-12-07FDA Approved: FENOFIBRATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves Mylan's original ANDA for fenofibrate, enabling the marketing of a generic fenofibrate product.
-
FDA approval · 2012-10-19FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC’s supplemental application for fenofibrate, authorizing the generic product's approval.
-
FDA approval · 2012-09-05FDA Approved: FENOFIBRIC ACID — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for fenofibric acid from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2012-08-31FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters), enabling changes to its labeling as requested by Waylis …
-
FDA approval · 2012-07-26FDA Approved: VASCEPA — Original Application (Amarin Pharma Inc.)
FDA approved Vascepa (icosapent ethyl) under its Original Application for use in adults with severe hypertriglyceridemia to reduce triglycer…
-
FDA approval · 2012-03-01FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' supplemental application for fenofibrate.
-
FDA approval · 2012-03-01FDA Approved: FENOFIBRATE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's original application (ANDA090859) for a generic fenofibrate product, authorizing its marketi…
-
FDA approval · 2012-02-07FDA Approved: FENOFIBRATE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
The FDA approved a supplemental application for fenofibrate from Rhodes Pharmaceuticals L.P., authorizing changes to the product under an ex…
-
FDA approval · 2011-09-19FDA Approved: LOVAZA — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for Lovaza (omega-3-acid ethyl esters) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2011-06-27FDA Approved: FENOFIBRATE — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for fenofibrate from Amneal Pharmaceuticals NY LLC under the ANDA. The approval confirms changes…